文献速递糖尿病肥胖与代谢综合征

2型糖尿病患者减重手术后体重减轻有限:脂肪组织中的预测变量

Limited Bariatric Surgery-induced Weight Loss in Subjects With Type 2 Diabetes: Predictor Variables in Adipose Tissue.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

在1659例受试者队列中,2型糖尿病独立关联中期末体重减轻少5%;在48对匹配受试者中,皮下脂肪组织ATG7表达是术后1年体重减轻有限的独立预测因子,其加入临床模型显著改善体重减轻变异解释度。

要点

  • 2型糖尿病独立关联减重手术后中期末体重减轻少5%。
  • 皮下脂肪组织ATG7表达是术后1年体重减轻有限的独立预测因子。
  • ATG7加入临床模型显著改善体重减轻变异解释度。

核心结论

  • 2型糖尿病是减重手术后体重减轻有限的重要决定因素,皮下脂肪组织巨自噬失调可能参与该关联。

研究设计与样本

  • 队列1纳入1659例受试者,其中2型糖尿病543例、无2型糖尿病1116例,评估减重手术后中期体重减轻轨迹。
  • 队列2纳入48对按年龄、性别、BMI和减重手术类型匹配的2型糖尿病与无2型糖尿病受试者,获取配对皮下和内脏脂肪组织样本。

主要发现

  • 队列1中2型糖尿病独立关联中期末体重减轻少5%。
  • 队列1中HbA1c、胰岛素治疗和减重手术前2型糖尿病药物数量仅与短期体重减轻结局相关。
  • 队列2中组间脂肪组织多个差异表达基因被识别,而脂肪细胞大小和纤维化相当。
  • 队列2中皮下脂肪组织ATG7表达是术后1年体重减轻有限的独立预测因子(β:-12.21 ± 4.41,P = .008)。
  • 将ATG7加入临床模型显著改善体重减轻变异解释度(R2 = 0.131 vs R2 = 0.248,F变化P = .009)。

关键数值与推荐

  • 2型糖尿病独立关联中期末体重减轻少5%。
  • 皮下脂肪组织ATG7表达预测术后1年体重减轻有限(β:-12.21 ± 4.41,P = .008)。
  • ATG7加入临床模型后R2 = 0.131 vs R2 = 0.248,F变化P = .009。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The impact of type 2 diabetes mellitus (T2D) at baseline on limited weight loss (WL) after bariatric surgery (BS) remains controversial, and the potential underlying mechanisms incompletely understood. OBJECTIVE: We aimed at gaining further insight on this relationship and identifying novel associations between adipose tissue (AT) parameters and short-term WL outcomes in subjects with or without T2D undergoing BS. METHODS: Mid-term WL trajectories after BS have been evaluated in a cohort of 1659 subjects (cohort 1) with (n = 543) and without T2D (n = 1116). Paired subcutaneous and visceral AT samples were obtained from a cohort of 48 pairs of subjects with and without T2D matched for age, sex, BMI, and type of BS (cohort 2). Differences in AT parameters between groups were evaluated and potential associations with WL response explored. RESULTS: T2D was independently associated with a 5% lesser mid-term WL in cohort 1, while HbA1c, insulin treatment, and number of T2D medications prior to BS were only related to short-term WL outcomes. In cohort 2, a number of differentially expressed genes in AT were identified between groups, while fat cell size and fibrosis were comparable. Subcutaneous ATG7 expression was found as an independent predictor of limited WL 1 year after surgery (β: -12.21 ± 4.41, P = .008) and its addition to a clinical model significantly improved the amount of WL variability explained (R2 = 0.131 vs R2 = 0.248, F change P = .009). CONCLUSION: Our results highlight the importance of T2D as determinant of limited WL following BS and suggest that dysregulated macroautophagy in subcutaneous AT may contribute to this association.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Osorio-Conles Ó, Jiménez A, Ibarzabal A, et al. Limited Bariatric Surgery-induced Weight Loss in Subjects With Type 2 Diabetes: Predictor Variables in Adipose Tissue. J Clin Endocrinol Metab. 2023. PMID: 37249080. doi:10.1210/clinem/dgad271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。